 ATLANTA, Dec. 08, 2020 GLOBE NEWSWIRE -- Alimera Sciences, Inc. Nasdaq: ALIM Alimera, a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute QA session with a panel of investors and analysts. 